Advanced search
Start date
Betweenand

Characterization and humanization of anti-Chikungunya and Zika Virus monoclonal antibodies

Grant number: 24/13269-2
Support Opportunities:Scholarships in Brazil - Technical Training Program - Technical Training
Start date: September 01, 2024
End date: January 31, 2026
Field of knowledge:Biological Sciences - Immunology - Applied Immunology
Principal Investigator:Gustavo Cabral de Miranda
Grantee:Bárbara Hamaguchi
Host Institution: Faculdade de Medicina (FM). Universidade de São Paulo (USP). São Paulo , SP, Brazil
Associated research grant:19/14526-0 - Development of vaccines against Streptococcus pyogenes and Chikungunya Virus based on virus like particles, AP.JP
News published in Agência FAPESP Newsletter about the scholarship:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
CORTES, NELSON; LIRA, ALINE; SILVA, JAQUELINE D. Q.; CARVALHO, EVELYN; PRATES-SYED, WASIM A.; HAMAGUCHI, BARBARA; DURAES-CARVALHO, RICARDO; BALAN, ANDREA; CAMARA, NIELS O. S.; CABRAL-MARQUES, OTAVIO; et al. A VLPs based vaccine protects against Zika virus infection and prevents cerebral and testicular damage. NPJ VACCINES, v. 10, n. 1, p. 12-pg., . (23/13991-7, 20/04667-3, 21/03508-1, 19/01255-9, 19/14526-0, 21/03684-4, 21/03102-5, 21/08468-8, 24/13269-2)